Clinical study groups

arc intends to provide support for large scale clinical trials and related studies by working with health care providers (e.g. NHS) and other bodies (e.g. pharmaceutical industry). The goal is to harness expertise, facilities and resources to support arc goals. Details about the new scheme can be found here.

Seven Clinical Studies Groups (CSG's) in the major disease areas of interest to arc have been established. These groups will provide the consensus opinion on the strategy for clinical trial and related research and will be the predominant vehicle by which arc resources such activities. Overall the approach the groups will use to develop strategy is here. The groups will be charged with developing nationally agreed strategies in their areas and the specific approaches to be adopted by each group can be found by linking on the corresponding group below.

 

Group Chair
Adult inflammatory arthritis CSG Professor John Isaacs
Spondyloarthropathies CSG Professor Hill Gaston
Auto-immune rheumatic disorders CSG Professor David Isenberg
Osteoarthritis and crystal diseases CSG Professor Phil Conaghan
Metabolic bone disease CSG Professor David Reid
Musculoskeletal pain disorders CSG Professor Elaine Hay
Paediatric Rheumatology CSG Dr Michael Beresford

 

Funding update

Please click here for an update on the clinical trials funding.

 

National Collections of Clinical Data and Associated Biological Materials

arc has funded and continues to receive requests for the support of the establishment of banks for specific diseases of clinical data, with associated biological materials, such as DNA, serum and biopsy specimens.

For arc's current position regarding its support for such initiatives and in particular how they must be integrated with strategy emerging from the newly developed CSGs please click here.